PHASE II TRIAL OF DASATINIB IN TARGET SELECTED PATIENTS WITH RECURRENT GLIOBLASTOMA (RTOG 0627) Conference

Lassman, Andrew B, Wang, Meihua, Gilbert, Mark R et al. (2011). PHASE II TRIAL OF DASATINIB IN TARGET SELECTED PATIENTS WITH RECURRENT GLIOBLASTOMA (RTOG 0627) . NEURO-ONCOLOGY, 13 64-64.

cited authors

  • Lassman, Andrew B; Wang, Meihua; Gilbert, Mark R; Aldape, Kenneth D; Beumer, Jan J; Wright, John; Takebe, Naoko; Puduvalli, Vinay K; Hormigo, Adilia; Gaur, Rakesh; Werner-Wasik, Maria; Mehta, Minesh P

sustainable development goals

authors

publication date

  • November 1, 2011

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

publisher

  • OXFORD UNIV PRESS INC

start page

  • 64

end page

  • 64

volume

  • 13